| Name | Title | Contact Details |
|---|
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.
Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.
Healthcare Interactive, Inc. (HCIactive) is dedicated to revolutionizing the administration and delivery of healthcare. Through our patented, integrative technology and supplemental ancillary services, we afford clients the freedom, control and energy to provide high-performance plan solutions that mitigate risk and improve member outcomes. Disparate plan functions, such as enrollment and eligibility, incentive management and population health are seamlessly conducted through our single-source, cloud-based platform. The outcome: greater operational efficiency, actionable performance data, increased member participation, and overall reduced healthcare costs. Founded in 2006, HCIactive is the progressive leader in delivering integrated, health plan solutions to TPA`s, brokers, health systems, providers and their customers. Our executive leadership team is comprised of seasoned professionals who have established successful track-records in the healthcare industry with over 85 years of combined experience.
Delaware Physicians Care is a Newark, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our goal is to advance knowledge and propose crosssectoral strategies and endeavours that will improve the health and well-being of Québecers. The Institut national de santé publique du Québec (INSPQ) was created in 1998 following the adoption of its act of incorporation (RSQ, chapter I-13.1.1). Its experts come from fields as distinct as applied science, health sciences, social sciences, and humanities and work with the health and social services network to develop and pool public health knowledge and skills.